Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Doravirine plus raltegravir dual therapy maintenance in virologically suppressed HIV-1 infection
2019-004195-19Phase 2Active
- Sponsor
- Centre de Recherche et d'Etudes sur la Pathologie Tropicale et le Sida
- Start
- Mar 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of doravirine and raltegravir in human immunodeficiency virus infection (HIV) (2 arms), sponsored by Centre de Recherche et d'Etudes sur la Pathologie Tropicale et le Sida. Started Mar 2020; status: active.
02
Drugs
doravirineraltegravir
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on 2019-004195-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004195-19.